Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study

16 Apr 2020

Abstract excerpt

At present, novel Coronavirus (2019-nCoV, the causative agent of COVID-19) has caused worldwide social and economic disruption. The disturbing statistics of this infection promoted us to develop an effective vaccine candidate against the COVID-19. In this study, bioinformatics approaches were employed to design and introduce a novel multi-epitope vaccine against 2019-nCoV that can potentially trigger both CD4+...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy and Immune Responses
Share to Pneumonia and Respiratory Infections
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32295479
DOI: 10.1080/07391102.2020.1756411

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico studyPMID 32295479Read ↗

Designing a new multi epitope-based vaccine against COVID-19 disease: an immunoinformatic study based on reverse vaccinology approachSemantic proximity Read ↗

Structural basis to design multi-epitope vaccines against Novel Coronavirus 19 (COVID19) infection, the ongoing pandemic emergency: an in silico approachSemantic proximity Read ↗

Identification of potential vaccine candidates against <i>SARS-CoV-2</i> , A step forward to fight COVID-19: A Reverse Vaccinology ApproachSemantic proximity Read ↗

Design of multi epitope-based peptide vaccine against E protein of human COVID-19: An immunoinformatics approachSemantic proximity Read ↗

Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and ValidationSemantic proximity Read ↗

In silico Design of novel Multi-epitope recombinant Vaccine based on Coronavirus surface glycoproteinSemantic proximity Read ↗

A Putative Prophylactic Solution for COVID-19: Development of Novel Multiepitope Vaccine Candidate against SARS-COV-2 by Comprehensive Immunoinformatic and Molecular Modelling ApproachSemantic proximity Read ↗

Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approachesSemantic proximity Read ↗

A Putative Prophylactic Solution for COVID-19: Development of Novel Multiepitope Vaccine Candidate against SARS‐COV‐2 by Comprehensive Immunoinformatic and Molecular Modelling ApproachSemantic proximity Read ↗

Multi-epitope vaccine design using an immunoinformatics approach for 2019 novel coronavirus (SARS-CoV-2)Semantic proximity Read ↗

Pangenome analysis of SARS-CoV2 strains to Identify Potential vaccine targets by Reverse VaccinologySemantic proximity Read ↗

Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and <i>in silico</i> approachesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.